Corticotropin-Releasing Hormone: Physiology and What Research Reports
Corticotropin-releasing hormone (CRH) is a 41-amino-acid hypothalamic peptide that triggers pituitary ACTH release and, in turn, adrenal cortisol output — the opening step of the hypothalamic–pituitary–adrenal axis. It acts through two G-protein-coupled receptors, CRHR1 and CRHR2. Published work also describes CRH-expressing neurons outside the hypothalamus that researchers have linked to sleep architecture, social behaviour, pain-related anxiodepression and anaesthesia recovery in rodents, plus reported associations with leptin signalling, immune tissue and skin conditions.
What corticotropin-releasing hormone is
Corticotropin-releasing hormone (CRH), also called corticotropin-releasing factor (CRF), is a 41-amino-acid neuropeptide described in a 2022 review as the principal initiator of the hypothalamic–pituitary–adrenal (HPA) axis and a coordinator of the endocrine stress response (PMID 36552294). The same review reported that CRH released from the hypothalamus reaches the anterior pituitary through the portal circulation, where it drives secretion of adrenocorticotropic hormone (ACTH), which then stimulates adrenal glucocorticoid output (PMID 36552294). Because of that position at the top of the cascade, CRH is often the reference point when readers encounter terms such as HPA axis, cortisol regulation or stress peptides.
Where CRH is produced
The classical source is the paraventricular nucleus of the hypothalamus, and a 2022 review reported that hypothalamic CRH neurons are the drivers of pituitary ACTH release in the neuroendocrine stress circuit (PMID 36552294). A 2024 mouse study manipulated hypothalamic CRH neurons and reported that they modulated sevoflurane anaesthesia and post-anaesthesia stress responses, confirming their activity outside purely endocrine readouts (PMID 39526880).
Separate rodent studies have described CRH-expressing neurons in specific extrahypothalamic regions. Researchers reported CRH neurons in the prefrontal cortex projecting to the lateral septum (PMID 37669667), in the hippocampus with projections toward prefrontal cortex (PMID 38241377), in the nucleus accumbens projecting to the bed nucleus of the stria terminalis (PMID 38980648), and in the piriform cortex projecting to the amygdala (PMID 40945515). A 2022 review also reported CRH and CRH-receptor expression in peripheral tissues, supporting a role beyond the brain (PMID 36552294).
Receptors and signalling
A 2002 review of CRH receptors reported that CRH acts through G-protein-coupled receptors of the class-B family, with CRHR1 and CRHR2 subtypes differing in distribution and ligand preference (PMID 12196108). That review also reported that receptor variants and related ligands such as the urocortins contribute to the pharmacological complexity of the system (PMID 12196108).
| Element | What the cited literature reported |
|---|---|
| CRH peptide | 41-amino-acid peptide initiating the HPA axis and ACTH release (PMID 36552294) |
| CRHR1 / CRHR2 | Class-B G-protein-coupled receptor subtypes with distinct distribution and ligand selectivity (PMID 12196108) |
| CRHR1 in skin | CRH and CRHR1 gene expression examined in vitiligo skin samples (PMID 27663146) |
| Therapeutic interest | A 2022 review discussed CRH-system targets as therapeutic opportunities (PMID 36552294) |
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeWhat research reports about CRH function
Stress axis and hormone output
The 2022 review reported that CRH-driven ACTH and glucocorticoid release is subject to negative feedback, and framed dysregulation of this loop as relevant to stress-related and metabolic disease (PMID 36552294). A 2019 review reported a metabolic association between leptin and CRH, describing interactions between adipose-derived leptin signalling and the CRH system (PMID 30727936).
Sleep and arousal
A 2025 study reported that CRH modulated non-REM sleep consolidation through the thalamic reticular nucleus (PMID 40830097). In a 2024 study, researchers reported that nucleus accumbens CRH neurons projecting to the bed nucleus of the stria terminalis promoted wakefulness and a positive affective state (PMID 38980648).
Social behaviour
A 2023 study reported that CRH signalling from prefrontal cortex to lateral septum suppressed interaction with familiar mice (PMID 37669667). A 2025 study reported that CRH signalling from piriform cortex to amygdala mediated social homophily in a model of opioid addiction (PMID 40945515).
Pain-related affect
A 2024 study reported that CRH neurons controlled trigeminal neuralgia-induced anxiodepression via a hippocampus-to-prefrontal circuit (PMID 38241377).
Immune tissue and sex differences
A 2025 study reported that androgen receptors in CRH neurons mediated the sexual dimorphism in restraint-induced thymic atrophy (PMID 40106355). Researchers examining skin disease reported on CRH and CRHR1 gene expression in vitiligo (PMID 27663146).
How CRH is measured and studied
Approaches in the cited literature fall into a few broad categories:
- Circuit manipulation in rodents. Studies targeted defined CRH neuron populations and their projections, for example prefrontal-to-lateral-septum signalling (PMID 37669667) and hypothalamic CRH neurons during sevoflurane anaesthesia (PMID 39526880).
- Sleep and EEG readouts. Researchers used sleep-stage measures to report effects on NREM sleep consolidation (PMID 40830097) and wakefulness (PMID 38980648).
- Gene-expression analysis in tissue. CRH and CRHR1 transcripts were quantified in vitiligo skin (PMID 27663146).
- Human neuroimaging with CRH administration. A 2017 study in healthy individuals examined whether CRH administration related to dopamine release (PMID 27951520).
- Receptor pharmacology. A receptor-focused review summarised subtype distribution and ligand interactions (PMID 12196108).
Tracking research? Log entries with dates, lots and notes — records, never plans.
Get the appWhy the term matters to peptide readers
CRH appears constantly in discussions of stress physiology, cortisol and the HPA axis, and it is a reference point for understanding how other peptides are described as "HPA-modulating". The 2022 review reported that components of the CRH system have been explored as therapeutic targets, which is why receptor names such as CRHR1 recur in pharmacology literature (PMID 36552294). CRH itself is a physiological hormone studied in laboratory and clinical research settings, not a consumer product, and the verified studies summarised here are descriptive rather than prescriptive. This page is for educational purposes only and is not medical advice; consult a licensed physician for any question about health, hormones or laboratory testing.
CRH and Adverse Events: What Studies Report
The verified papers here are largely mechanistic and did not set out to catalogue adverse events of CRH in people. Indirect safety-relevant observations included a 2025 rodent report that stress-related signalling through androgen receptors in CRH neurons mediated restraint-induced thymic atrophy, an immune-tissue change (PMID 40106355), and a 2024 report that hypothalamic CRH neurons modulated post-anaesthesia stress responses (PMID 39526880). A 2022 review discussed dysregulated CRH signalling in the context of stress-related disorders while framing the system as a therapeutic target (PMID 36552294). Human tolerability data were not the focus of the human imaging study cited above, which examined dopamine-related outcomes after CRH administration in healthy individuals (PMID 27951520).
Want the full course? Every compound, evidence-graded and cited, inside PeptideU.
Start learning freeLimitations of the evidence
Most of the circuit-level findings above came from rodent experiments, including the social-interaction (PMID 37669667), anxiodepression (PMID 38241377) and sleep studies (PMID 40830097), so translation to human physiology remains uncertain. Receptor pharmacology reviews noted the complexity of subtypes and related ligands, which complicates simple cause-and-effect statements about CRH activity (PMID 12196108).
References
- Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities (Biology, 2022)
- Corticotropin-releasing hormone receptors (Biochemical Society Transactions, 2002)
- Corticotropin-releasing hormone signaling from prefrontal cortex to lateral septum suppresses interaction with familiar mice (Cell, 2023)
- Corticotropin-releasing hormone neurons control trigeminal neuralgia-induced anxiodepression via a hippocampus-to-prefrontal circuit (Science Advances, 2024)
- Nucleus Accumbens Corticotropin-Releasing Hormone Neurons Projecting to the Bed Nucleus of the Stria Terminalis Promote Wakefulness and Positive Affective State (Neuroscience Bulletin, 2024)
- Corticotropin-releasing hormone modulates NREM sleep consolidation through the thalamic reticular nucleus (Nature Communications, 2025)
- Corticotropin-releasing hormone signaling from piriform cortex to amygdala mediates social homophily in opioid addiction (Neuron, 2025)
- Corticotropin-releasing hormone and dopamine release in healthy individuals (Psychoneuroendocrinology, 2017)
- Metabolic Association between Leptin and the Corticotropin Releasing Hormone (Endocrine, Metabolic & Immune Disorders Drug Targets, 2019)
- Corticotropin-releasing hormone (CRH) and CRH receptor 1 gene expression in vitiligo (Clinical and Experimental Dermatology, 2016)
- Androgen receptors in corticotropin-releasing hormone neurons mediate the sexual dimorphism in restraint-induced thymic atrophy (PNAS, 2025)
- Hypothalamic corticotropin-releasing hormone neurons modulate sevoflurane anesthesia and the post-anesthesia stress responses (eLife, 2024)
Frequently asked questions
What is corticotropin-releasing hormone?▾
A 2022 review described corticotropin-releasing hormone as a 41-amino-acid neuropeptide that initiates the hypothalamic–pituitary–adrenal axis by driving pituitary ACTH release, which in turn stimulates adrenal glucocorticoid output (PMID 36552294). It is a physiological hormone studied in laboratory and clinical research, and the term is often abbreviated CRH or called corticotropin-releasing factor (CRF).
Which receptors does CRH act through?▾
A receptor-focused review reported that CRH signals through class-B G-protein-coupled receptors, with CRHR1 and CRHR2 subtypes differing in tissue distribution and ligand preference, and noted that related ligands such as the urocortins add pharmacological complexity (PMID 12196108). CRHR1 expression has also been examined in human skin tissue in vitiligo research (PMID 27663146).
Is CRH found outside the hypothalamus?▾
Yes. Rodent studies reported CRH neurons in the prefrontal cortex projecting to lateral septum (PMID 37669667), the hippocampus projecting toward prefrontal cortex (PMID 38241377), the nucleus accumbens projecting to the bed nucleus of the stria terminalis (PMID 38980648), and the piriform cortex projecting to amygdala (PMID 40945515). A review also described peripheral CRH-system expression (PMID 36552294).
What has research reported about CRH and sleep?▾
A 2025 study reported that CRH modulated non-REM sleep consolidation through the thalamic reticular nucleus (PMID 40830097). A separate 2024 study reported that nucleus accumbens CRH neurons projecting to the bed nucleus of the stria terminalis promoted wakefulness and a positive affective state (PMID 38980648). Both used rodent models, so human relevance remains unestablished.
Has CRH been studied in humans?▾
Yes, though less often than in rodents among the papers summarised here. A 2017 study in healthy individuals examined corticotropin-releasing hormone administration in relation to dopamine release (PMID 27951520), and researchers measured CRH and CRHR1 gene expression in human vitiligo skin samples (PMID 27663146). A 2022 review discussed therapeutic interest in the CRH system (PMID 36552294).
What do studies report about CRH and stress-related harm?▾
A 2025 rodent study reported that androgen receptors in CRH neurons mediated the sex difference in restraint-induced thymic atrophy, an immune-tissue effect (PMID 40106355). A 2024 study reported that hypothalamic CRH neurons modulated sevoflurane anaesthesia and post-anaesthesia stress responses (PMID 39526880). Neither was designed as a human safety trial, so adverse-event data in people are limited.
Why does CRH come up in peptide discussions?▾
CRH sits at the top of the stress-hormone cascade, so it is a reference point whenever cortisol or HPA-axis effects are described (PMID 36552294). A 2019 review also reported a metabolic association between leptin and CRH, linking the peptide to appetite and energy-balance signalling literature (PMID 30727936). This is educational context only, not medical advice.
Track it. Calculate it. Actually understand it.
References
This page summarises published research for education — it is not medical advice, and nothing here is a recommendation to use, purchase, or dose any substance. Study parameters described are what researchers reported, not instructions. Consult a qualified clinician before any health decision.